Kalyan Handique: President and CEO at DeNovo Sciences in Plymouth. DeNovo Sciences is developing a microfluidic platform for detection of cancer from blood as an alternative to painful biopsies. The company was the grand prize winner of the 2011 Accelerate Michigan competition and won the first place award for new business ideas from the Great Lakes Entrepreneur’s Quest. Previously, Handique was vice president of R&D systems development at Becton Dickinson Diagnostic Systems. He became a part of Beckton when it acquired Handylab, a molecular diagnostic company Handique co-founded, for more than $275 million. Handique started Handylab in 2000 while completing his doctoral degree at the University of Michigan and played a pivotal role in forming its vision and core technical team. Under his leadership, HandyLab launched a series of integrated molecular diagnostic products in the hospital testing market. Handique is the author of numerous journal articles and has more than 50 patents and outstanding patent applications. He also serves as an advisor to Augment Ventures and the Frankel Fund and is on the board of directors of 3D Biomatrix. Handique received his bachelor’s degree in technology from the Indian Institute of Technology in Bombay and his doctorate in microfluidics from the University of Michigan.